Company: TVRD
Filing Date: 2025-02-14
Form Type: 424B3
Source: 0001104659-25-014310
Chunk: 399

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: 424B3
Chunk 399
---
 or themselves in determining to recommend that stockholders vote for the proposals. In addition, Cara’s officers have interests in the Merger that may conflict with your interests as a stockholder. See the section titled “ The Merger — Interests of Cara Directors and Executive Officers in the Merger ” for a further discussion of these considerations. Equity Compensation Plan Information The following table provides information as of December 31, 2024 with respect to the shares of Cara common stock that may be issued under Cara’s existing equity compensation plans.

| Plan Category                                              | ​ | ​ | Number of securities tobe issued upon exerciseof outstanding options,warrants and rights |   |         |   | ​ | ​ | Weighted averageexercise price ofoutstanding options,warrants and rights(2) |   |       |   | ​ | ​ | Number of securitiesremaining available forfuture issuance underequity compensationplans (excludingsecurities infirst column)(3) |   |           |   | ​ |
|:-----------------------------------------------------------|:--|:--|:-----------------------------------------------------------------------------------------|:--|--------:|:--|:--|:--|:----------------------------------------------------------------------------|:--|------:|:--|:--|:--|:---------------------------------------------------------------------------------------------------------------------------------|:--|----------:|:--|:--|
| Equity compensation plans approved by security holders﻿(1) | ​ | ​ | ​                                                                                        | ​ | 420,373 | ​ | ​ | ​ | ​                                                                           | $ | 86.35 | ​ | ​ | ​ | ​                                                                                                                                | ​ |   494,275 | ​ | ​ |
| Equity compensation plans not approved by security holders | ​ | ​ | ​                                                                                        | ​ |       — | ​ | ​ | ​ | ​                                                                           | $ |     — | ​ | ​ | ​ | ​                                                                                                                                | ​ | 25,000(4) | ​ | ​ |
| Total                                                      | ​ | ​ | ​                                                                                        | ​ | 420,373 | ​ | ​ | ​ | ​                                                                           | $ | 86.35 | ​ | ​ | ​ | ​                                                                                                                                | ​ |   519,275 | ​ | ​ |

(1) Includes the 2014 Plan. (2) Cara grants full value RSUs which skew the weighted average exercise price down since there is no strike price. Excluding RSUs, Cara had 340,460 securities issued from plans approved by security holders, comprised of stock options, with a weighted average exercise price